Literature DB >> 18771457

Discontinuing medications: a novel approach for revising the prescribing stage of the medication-use process.

Kevin T Bain1, Holly M Holmes, Mark H Beers, Vittorio Maio, Steven M Handler, Stephen G Pauker.   

Abstract

Thousands of Americans are injured or die each year from adverse drug reactions, many of which are preventable. The burden of harm conveyed by the use of medications is a significant public health problem, and therefore, improving the medication-use process is a priority. Recent and ongoing efforts to improve the medication-use process have focused primarily on improving medication prescribing, and not much emphasis has been put on improving medication discontinuation. A formalized approach for rationally discontinuing medications is a necessary antecedent to improving medication safety and improving the nation's quality of care. This article proposes a conceptual framework for revising the prescribing stage of the medication-use process to include discontinuing medications. This framework has substantial practice and research implications, especially for the clinical care of older persons, who are particularly susceptible to the adverse effects of medications.

Entities:  

Mesh:

Year:  2008        PMID: 18771457      PMCID: PMC3119470          DOI: 10.1111/j.1532-5415.2008.01916.x

Source DB:  PubMed          Journal:  J Am Geriatr Soc        ISSN: 0002-8614            Impact factor:   5.562


  29 in total

1.  Open-label, multicenter, phase 3 extension study of the safety and efficacy of donepezil in patients with Alzheimer disease.

Authors:  R S Doody; D S Geldmacher; B Gordon; C A Perdomo; R D Pratt
Journal:  Arch Neurol       Date:  2001-03

2.  Comparing the power of the discontinuation design to that of the classic randomized design on time-to-event endpoints.

Authors:  William B Capra
Journal:  Control Clin Trials       Date:  2004-04

3.  The medical office of the 21st century (MOXXI): effectiveness of computerized decision-making support in reducing inappropriate prescribing in primary care.

Authors:  Robyn Tamblyn; Allen Huang; Robert Perreault; André Jacques; Denis Roy; James Hanley; Peter McLeod; Réjean Laprise
Journal:  CMAJ       Date:  2003-09-16       Impact factor: 8.262

4.  Incidence and preventability of adverse drug events among older persons in the ambulatory setting.

Authors:  Jerry H Gurwitz; Terry S Field; Leslie R Harrold; Jeffrey Rothschild; Kristin Debellis; Andrew C Seger; Cynthia Cadoret; Leslie S Fish; Lawrence Garber; Michael Kelleher; David W Bates
Journal:  JAMA       Date:  2003-03-05       Impact factor: 56.272

5.  Polypharmacy in palliative care: can it be reduced?

Authors:  N Y Koh; W H Koo
Journal:  Singapore Med J       Date:  2002-06       Impact factor: 1.858

6.  Predictors of normotension on withdrawal of antihypertensive drugs in elderly patients: prospective study in second Australian national blood pressure study cohort.

Authors:  Mark R Nelson; Chris M Reid; Henry Krum; Tui Muir; Philip Ryan; John J McNeil
Journal:  BMJ       Date:  2002-10-12

7.  Early withdrawal of statin therapy in patients with non-ST-segment elevation myocardial infarction: national registry of myocardial infarction.

Authors:  Frederick A Spencer; Gregg C Fonarow; Paul D Frederick; R Scott Wright; Nathan Every; Robert J Goldberg; Joel M Gore; Wei Dong; Richard C Becker; William French
Journal:  Arch Intern Med       Date:  2004-10-25

8.  There is no evidence for an increase in acute coronary syndromes after short-term abrupt discontinuation of statins in stable cardiac patients.

Authors:  Mary P McGowan
Journal:  Circulation       Date:  2004-10-11       Impact factor: 29.690

9.  Statin treatment withdrawal in ischemic stroke: a controlled randomized study.

Authors:  M Blanco; F Nombela; M Castellanos; M Rodriguez-Yáñez; M García-Gil; R Leira; I Lizasoain; J Serena; J Vivancos; M A Moro; A Dávalos; J Castillo
Journal:  Neurology       Date:  2007-08-28       Impact factor: 9.910

10.  The quality of pharmacologic care for vulnerable older patients.

Authors:  Takahiro Higashi; Paul G Shekelle; David H Solomon; Eric L Knight; Carol Roth; John T Chang; Caren J Kamberg; Catherine H MacLean; Roy T Young; John Adams; David B Reuben; Jerry Avorn; Neil S Wenger
Journal:  Ann Intern Med       Date:  2004-05-04       Impact factor: 25.391

View more
  73 in total

1.  Prevalence of potentially preventable unplanned hospitalizations caused by therapeutic failures and adverse drug withdrawal events among older veterans.

Authors:  Zachary A Marcum; Mary Jo V Pugh; Megan E Amuan; Sherrie L Aspinall; Steven M Handler; Christine M Ruby; Joseph T Hanlon
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2012-03-01       Impact factor: 6.053

Review 2.  Drug therapy optimization at the end of life.

Authors:  Alfonso J Cruz-Jentoft; Benoit Boland; Lourdes Rexach
Journal:  Drugs Aging       Date:  2012-06-01       Impact factor: 3.923

3.  A Multicomponent Intervention to Optimize Psychotropic Drug Prescription in Elderly Nursing Home Residents: An Italian Multicenter, Prospective, Pilot Study.

Authors:  Luca Pasina; Alessandra Marengoni; Simona Ghibelli; Flavio Suardi; Codjo D Djade; Alessandro Nobili; Carlotta Franchi; Gianbattista Guerrini
Journal:  Drugs Aging       Date:  2016-02       Impact factor: 3.923

4.  Is self-rated health an independent prognostic factor of six-week mortality in older patients hospitalized for an acute condition?

Authors:  Claire Godard-Sebillotte; Moustapha Dramé; Tatiana Basileu; Jean-Luc Fanon; Lidvine Godaert
Journal:  Qual Life Res       Date:  2016-02-26       Impact factor: 4.147

5.  Central Nervous System Medication Burden and Serious Falls in Older Nursing Home Residents.

Authors:  Joseph T Hanlon; Xinhua Zhao; Jennifer G Naples; Sherrie L Aspinall; Subashan Perera; David A Nace; Nicholas G Castle; Susan L Greenspan; Carolyn T Thorpe
Journal:  J Am Geriatr Soc       Date:  2017-02-02       Impact factor: 5.562

6.  Pharmacotherapy in Older Adults with Cardiovascular Disease: Report from an American College of Cardiology, American Geriatrics Society, and National Institute on Aging Workshop.

Authors:  Janice B Schwartz; Kenneth E Schmader; Joseph T Hanlon; Darrell R Abernethy; Shelly Gray; Jacqueline Dunbar-Jacob; Holly M Holmes; Michael D Murray; Robert Roberts; Michael Joyner; Josh Peterson; David Lindeman; Ming Tai-Seale; Laura Downey; Michael W Rich
Journal:  J Am Geriatr Soc       Date:  2018-12-07       Impact factor: 5.562

Review 7.  Deprescribing in Older Nursing Home Patients: Focus on Innovative Composite Measures for Dosage Deintensification.

Authors:  Sherrie L Aspinall; Joseph T Hanlon; Joshua D Niznik; Sydney P Springer; Carolyn T Thorpe
Journal:  Innov Aging       Date:  2017-12-20

8.  The challenges of symptom management for patients with multimorbidity in research and practice: a thematic review.

Authors:  Laura A Petrillo; Christine S Ritchie
Journal:  Prog Palliat Care       Date:  2016-07-26

9.  Tapering or abrupt cessation of proton pump inhibitors?

Authors:  Emily Reeve; Sarah Hilmer
Journal:  Eur J Clin Pharmacol       Date:  2017-03-22       Impact factor: 2.953

10.  Antihypertensive Drug Deintensification and Recurrent Falls in Long-Term Care.

Authors:  Wei Song; Orna Intrator; Sei Lee; Kenneth Boockvar
Journal:  Health Serv Res       Date:  2018-10-23       Impact factor: 3.402

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.